A Pharmaceutical Market Europe (PME) Q&A article authored by Gretchen Goller and Valerie Legrand, discussing the challenges of rare disease trials, including those of recruitment and retention unique to rare disease studies. The article also provides insights on solutions to these challenges.

Download Article

Rare and orphan diseases insights

ICON's Rare and Orphan Diseases team provides analysis including whitepapers, blogs and contributions to media and industry conversations relating to all aspects of rare and orphan diseases in clinical trials.

Read more